About this trial
Spinal anesthesia is a commonly employed technique for lower abdominal surgeries, providing effective anesthesia and analgesia with minimal systemic effects. In cancer patients undergoing such procedures, careful consideration of anesthetic techniques is crucial, given their often-compromised physiological state and the need to minimize postoperative complications. Two approaches to administering spinal anesthesia are Ultrasound (US)-guided and the traditional landmark-based technique.
the aim of the study :To evaluate the efficacy, safety and feasibility of US-guided spinal anesthesia versus the landmark-based technique in cancer patients undergoing lower abdominal surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >18 years old
Both sex
patients with a body mass index (BMI) of 18-40 kg/m2
American Society of Anesthesiologists (ASA) physical status classification of I to III.
Disqualifiers
• Patients have a contraindication for regional anesthesia, e.g. coagulopathy.
Failed or unsatisfactory intrathecal block.
Patients with known hypersensitivity to amide local anesthetics.
Local injection site infection or spinal deformity.
Trial design
Parallel
Treatments tested in this trial
spinal anesthesia
Procedure/Surgeryspinal anesthesia after us-assisted technique
spinal anesthesia
Procedure/Surgeryspinal anesthesia using the surface landmark-guided
Treatment groups
Trial outcomes
Primary outcomes
the first-pass success rate of Combined spinal-epidural anesthesia
first-pass success was defined as the needle reaching the subarachnoid space within a single insertion attempt, without redirection
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: